Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jun 13 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited reported that its injectables manufacturing facility at Zydus Biotech Park in Changodar, Ahmedabad, underwent a USFDA inspection. This announcement serves as a disclosure in accordance with SEBI regulations. The company aims to inform the exchange members and investors about this development.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated Jun 13, 2023, titled "USFDA inspection at Zydus injectables manufacturing facility at Zydus Biotech Park, concludes with Nil observations".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases